Yanhong Chen
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Correction: Screening of placenta accreta spectrum disorder using maternal serum biomarkers and clinical indicators: a case-control study.
Journal: BMC pregnancy and childbirth
Published: May 12, 2026
Risk factors for acute fatty liver of pregnancy complicated by acute liver failure: a retrospective study of 133 cases.
Journal: BMC pregnancy and childbirth
Published: April 16, 2024
Targeting the NLRP3 inflammasome in psoriasis.
Journal: International journal of dermatology
Published: November 06, 2023
Screening of placenta accreta spectrum disorder using maternal serum biomarkers and clinical indicators: a case-control study.
Journal: BMC pregnancy and childbirth
Published: March 31, 2023
Antagonizing interleukin-5 receptor ameliorates dextran sulfate sodium-induced experimental colitis in mice through reducing NLRP3 inflammasome activation.
Journal: European journal of pharmacology
Published: February 20, 2023
Predictors of intensive care unit admission in posterior reversible encephalopathy syndrome patients with preeclampsia or eclampsia: a 10-year retrospective study.
Journal: BMC pregnancy and childbirth
Published: November 09, 2022
Artemisinin-derived artemisitene blocks ROS-mediated NLRP3 inflammasome and alleviates ulcerative colitis.
Journal: International immunopharmacology
Published: September 06, 2022
Discovery of a Novel Oral Proteasome Inhibitor to Block NLRP3 Inflammasome Activation with Anti-inflammation Activity.
Journal: Journal of medicinal chemistry
Published: September 05, 2022
Bortezomib inhibits NLRP3 inflammasome activation and NF-κB pathway to reduce psoriatic inflammation.
Journal: Biochemical pharmacology
Published: August 18, 2022
In Vitro Antifungal Activity of Azoles and Other Antifungal Agents Against Pathogenic Yeasts from Vulvovaginal Candidiasis in China.
Journal: Mycopathologia
Published: August 08, 2022
Ciclopirox inhibits NLRP3 inflammasome activation via protecting mitochondria and ameliorates imiquimod-induced psoriatic inflammation in mice.
Journal: European journal of pharmacology
Published: March 21, 2022
Last Updated: 09/26/2026